One of the most well documented diets for enhancing health outcomes and reducing disease risk is the Mediterranean diet
Since then, additional trials have been published, further contributing to the growing body of evidence on the potential role of GLP-1 receptor agonists in PD management [29,30,31]
The frequency and intensity of surveillance should be individualized based on baseline cancer risk, duration of peptide therapy, and the presence of any concerning symptoms or clinical findings
Does GLP-1 anxiety feel like a panic attack
the TRIUMPH trials are ongoing, with full data needed before any regulatory submission to the MHRA or EMA can take place
GLP-1 drugs can: Help with weight loss Improve blood sugar control Support metabolic health So while GLP-1 agonists may not directly reduce cancer cells, they may be associated with better breast cancer outcomes by improving the underlying health conditions that influence risk and recurrence